The recent International Society of University Colorectal Surgeons Congress, held in Bologna Italy from June 23-26, 2012, featured three important presentations on Secca Therapy for Fecal Incontinence.
On Monday June 24, Steven Wexner, MD from the Cleveland Clinic, who has extensively studied Secca, presented Secca as a low cost, low complication alternative to surgical options for fecal incontinence. Later that same day, Professor Marco Frascio presented the results of his investigational Secca study. This study shows that Secca Therapy produced significant improvement in patient quality of life as well as resting and squeeze pressure. Professor Frascio also concluded that the therapeutic effect of Secca could be related to the improvement of sphincter function and restored anorectal sensitivity and recto-anal coordination.
On Tuesday June 25, Professor Roman Herman presented the results of his study that compared Secca Therapy to Biofeedback. This study proposed Secca therapy to be an ideal first line option based on patients outcomes and physiological results of Secca vs Biofeedback training. This study showed significant improvements in symptoms, increased resting and squeeze pressure, as well as decreased tissue compliance.
Professor Herman’s study concluded that:
- Secca was a safe and effective method of treatment for Fecal Incontinence.
- Secca significantly reduces the frequency and severity of symptoms, improves patient quality of life, and anorectal physiology compared to Biofeedback.
- Secca is more effective and stable as compared to Biofeedback.
- Because Secca is a safe, effective, and minimally invasive one-time treatment, it can be proposed as a first line therapy for the treatment of Fecal Incontinence.